文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Genome-scale modeling identifies dynamic metabolic vulnerabilities during the epithelial to mesenchymal transition.

作者信息

Bhowmick Rupa, Campit Scott, Katkam Shiva Krishna, Keshamouni Venkateshwar G, Chandrasekaran Sriram

机构信息

Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, USA.

Program in Chemical Biology, University of Michigan, Ann Arbor, MI, USA.

出版信息

Commun Biol. 2024 Dec 27;7(1):1704. doi: 10.1038/s42003-024-07408-7.


DOI:10.1038/s42003-024-07408-7
PMID:39730911
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11681178/
Abstract

Epithelial-to-mesenchymal transition (EMT) is a conserved cellular process critical for embryogenesis, wound healing, and cancer metastasis. During EMT, cells undergo large-scale metabolic reprogramming that supports multiple functional phenotypes including migration, invasion, survival, chemo-resistance and stemness. However, the extent of metabolic network rewiring during EMT is unclear. In this work, using genome-scale metabolic modeling, we perform a meta-analysis of time-course transcriptomics, time-course proteomics, and single-cell transcriptomics EMT datasets from cell culture models stimulated with TGF-β. We uncovered temporal metabolic dependencies in glycolysis and glutamine metabolism, and experimentally validated isoform-specific dependency on Enolase3 for cell survival during EMT. We derived a prioritized list of metabolic dependencies based on model predictions, literature mining, and CRISPR-Cas9 essentiality screens. Notably, enolase and triose phosphate isomerase reaction fluxes significantly correlate with survival of lung adenocarcinoma patients. Our study illustrates how integration of heterogeneous datasets using a mechanistic computational model can uncover temporal and cell-state-specific metabolic dependencies.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8f/11681178/1c6c7caf68e6/42003_2024_7408_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8f/11681178/bcafabd3b228/42003_2024_7408_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8f/11681178/fb33be8f127d/42003_2024_7408_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8f/11681178/743d24e35494/42003_2024_7408_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8f/11681178/1c6c7caf68e6/42003_2024_7408_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8f/11681178/bcafabd3b228/42003_2024_7408_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8f/11681178/fb33be8f127d/42003_2024_7408_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8f/11681178/743d24e35494/42003_2024_7408_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec8f/11681178/1c6c7caf68e6/42003_2024_7408_Fig7_HTML.jpg

相似文献

[1]
Genome-scale modeling identifies dynamic metabolic vulnerabilities during the epithelial to mesenchymal transition.

Commun Biol. 2024-12-27

[2]
Spatial Transcriptomics Unveils Regional Heterogeneity and Subclonal Dynamics in the Lung Adenocarcinoma Microenvironment.

Comput Methods Programs Biomed. 2025-10

[3]
Genome-wide CRISPR-Cas9 screening identifies ITGA8 responsible for abivertinib sensitivity in lung adenocarcinoma.

Acta Pharmacol Sin. 2025-5

[4]
Drug tolerance and persistence to EGFR inhibitor treatment are mediated by an ILK-SFK-YAP signaling axis in lung adenocarcinoma.

Oncogene. 2025-5-31

[5]
TLE1 drives EGFR-TKI resistance in EGFR-mutant lung adenocarcinoma through epithelial to mesenchymal transition.

Biochem Biophys Res Commun. 2025-8-15

[6]
Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation.

Sci Rep. 2025-7-1

[7]
Unraveling the role of GPCR signaling in metabolic reprogramming and immune microenvironment of lung adenocarcinoma: a multi-omics study with experimental validation.

Front Immunol. 2025-6-6

[8]
CDH3 promotes the progression of lung adenocarcinoma through driving epithelial-mesenchymal transition progress.

J Transl Med. 2025-8-8

[9]
A New Treatment Strategy for Lung Cancer With HDAC and Wnt/β-Catenin Pathway Inhibitors.

IUBMB Life. 2025-7

[10]
CENPA-driven transcriptional activation of ECT2 enhances EGFR inhibitor resistance in lung adenocarcinoma.

Biochem Biophys Res Commun. 2025-9-1

引用本文的文献

[1]
Metabolic Objectives and Trade-Offs: Inference and Applications.

Metabolites. 2025-2-6

本文引用的文献

[1]
Genomic and microenvironmental heterogeneity shaping epithelial-to-mesenchymal trajectories in cancer.

Nat Commun. 2023-2-11

[2]
Recent advances of IDH1 mutant inhibitor in cancer therapy.

Front Pharmacol. 2022-8-24

[3]
Altered propionate metabolism contributes to tumour progression and aggressiveness.

Nat Metab. 2022-4

[4]
UDP-glucose dehydrogenase expression is upregulated following EMT and differentially affects intracellular glycerophosphocholine and acetylaspartate levels in breast mesenchymal cell lines.

Mol Oncol. 2022-5

[5]
Sphingosine-1-phosphate/TGF-β axis drives epithelial mesenchymal transition in asthma-like disease.

Br J Pharmacol. 2022-4

[6]
Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer.

Br J Cancer. 2021-6

[7]
Pyruvate dehydrogenase kinases (PDKs): an overview toward clinical applications.

Biosci Rep. 2021-4-30

[8]
Integrated cross-study datasets of genetic dependencies in cancer.

Nat Commun. 2021-3-12

[9]
The metabolism of cancer cells during metastasis.

Nat Rev Cancer. 2021-3

[10]
Author Correction: An enolase inhibitor for the targeted treatment of ENO1-deleted cancers.

Nat Metab. 2021-1

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索